OptimizeRx (OPRX) Moves 5.4% Higher: Will This Strength Last? [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.9% loss over the past four weeks. The increase in share price can be attributed to higher demand for the company's innovative DAAP (Dynamic Audience Activation Platform) solution. The platform offers predictive and secure marketing solutions, which connect patients, HCPs and life sciences across a strong network of clinical and personal platforms. OPRX is witnessing increasing success in the conversion of the DAAP pipeline into closed deals. The company has more than 300 brands that it supports and it is looking to convert all of them to DAAP. It closed eight DAAP deals (which are direct pharma engagements) in the second quarter, taking the count to 17 deals for the first half of 2024. OPRX added that it has many DAAP deals in the pipeline, of which nearly half are from the DTC side of the business. It remains focused on cross-selling opportunities to
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ETGlobeNewswire
- OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total ValueGlobeNewswire
- OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare AudiencesGlobeNewswire
- OptimizeRx Co. (NASDAQ: OPRX) had its price target lowered by analysts at Royal Bank of Canada from $17.00 to $14.00. They now have an "outperform" rating on the stock.MarketBeat
- OptimizeRx Co. (NASDAQ: OPRX) had its price target lowered by analysts at Barclays PLC from $15.00 to $11.00. They now have an "equal weight" rating on the stock.MarketBeat
OPRX
Earnings
- 8/8/24 - Beat
OPRX
Sec Filings
- 10/15/24 - Form 4
- 10/7/24 - Form 4
- 10/7/24 - Form 4
- OPRX's page on the SEC website